Promonitor QUICK
Registration- Indications
- Immunological disorders
Company intelligence / Profile preview
Progenika has developed and commercialized several CE-marked molecular diagnostic platforms. Notably, its NGS-based familial hypercholesterolemia test was the first approved NGS assay for this indication in Europe. Its blood group genotyping platform BLOODchip® has global distribution through Grifols and supports improved transfusion safety. The company also offers Promonitor® kits for therapeutic drug monitoring of biologics in autoimmune diseases[6].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progenika Biopharma.